GIANTCR
LIVE

Serial Number

98501127

Owner

SCG Cell Therapy Pte Ltd.

Attorney

Alan Taboada

First Use Date

May 7, 2024

Filing Date

Apr 15, 2024

Add to watchlist:

No watchlists yet
View on USPTO

GIANTCR Trademark

Serial Number: 98501127

GIANTCR is a trademark filed by SCG Cell Therapy Pte Ltd. on April 15, 2024. The trademark is classified under Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

SCG Cell Therapy Pte Ltd. (3 trademarks)

138 Depot Road #04-02
Singapore 109683 , SG

Entity Type: 24

Trademark Details

Filing Date

April 15, 2024

Registration Date

Not Registered

First Use Anywhere

May 7, 2024

First Use in Commerce

September 4, 2025

Published for Opposition

February 18, 2025

Goods & Services

Culturing of cells for scientific research purposes; Cell culture services for scientific and research purposes, for others; Scientific research in the nature of conducting clinical trials for others; Providing medical and scientific research information in the field of clinical trials; Pharmaceutical research and development; Research and development in the field of pharmaceuticals for the pharmaceutical industry; Research and development in the field of biotechnology; Research and development in the field of diagnostic preparations; Research and development in the field of microorganisms and cells; Research and development of vaccines and medicines; Research and development services in the field of antibodies; Research and development services in the field of immunology; Advisory services relating to scientific research; Biochemical research and development; Biomedical research services; Biotechnology research; Chemical research and analysis; Clinical research in the fields of viral disease, cancer, and cell therapy; Consultancy in the field of pharmaceutical research; Consultancy relating to pharmaceutical research and development; Gene therapy research; Laboratory research services relating to pharmaceuticals; Medical research services; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific research and development; Stem cell research; Advisory services relating to gene therapy research

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 1, 2026 GNRN
NON-FINAL ACTION E-MAILED
Apr 1, 2026 GNRT
SU - NON-FINAL ACTION - WRITTEN
Apr 1, 2026 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Apr 1, 2026 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 1, 2026 AITU
USE AMENDMENT FILED
Oct 2, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
Oct 2, 2025 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 15, 2025 NOAM
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Mar 25, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 25, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 25, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 25, 2025 REAP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 18, 2025 NPUB
PUBLISHED FOR OPPOSITION
Feb 18, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 12, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 24, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 23, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 23, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 23, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 4, 2024 GNRN
NON-FINAL ACTION E-MAILED
Nov 4, 2024 GNRT
NON-FINAL ACTION WRITTEN
Nov 4, 2024 CNRT
ASSIGNED TO EXAMINER
Oct 29, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 27, 2024 NWOS
NEW APPLICATION ENTERED
Apr 15, 2024 NWAP